VEGFA and colorectal carcinoma: An animal experiment using the transplantation model of CRC cells demonstrated that a combination of PD-1 antibodies with VEGF inhibition achieved a strong and synergic antitumor effect, consistent with the previous finding that VEGF produced by tumors shapes the immunosuppressive microenvironment.